TTR and amyloidosis: The most common TTR mutant, V122I (p.V142I), is notably prevalent among African-Americans (3.0–3.9%) [28] resulting in a median survival of 25.6 months after diagnosis [23], which is slightly shorter than that in ATTRwt amyloidosis (43–75 months) [29].